HealthScience & Technology
News 0 of 33

Semaglutide Patent Expires, 40+ Generic Brands Expected Amid Quality & Regulatory Challenges

Target:UPSC GS-IIIMPSCSSC GATeachingPrelims MediumMains HighStatic GK Link
17 Mar 2026
~2 min
Source: Indian Express
Key Data:Over 40 generic brandsTemperature 2°C to 8°CDapagliflozin 100 brands
Practice MCQs from today's news ▸
What This Article Covers

1.Patent on semaglutide (a complex peptide drug for diabetes/obesity) expires, leading to an expected launch of over 40 generic brands in India.

2.While increasing affordability, the rapid market entry poses major challenges: maintaining manufacturing quality for complex injectables, ensuring cold-chain logistics, and preventing indiscriminate use.

3.Examiners may focus on the regulatory framework for generic drugs (CDSCO), pharmacovigilance, and lessons from past generics like Dapagliflozin.

The Big Picture
Prelims · MediumMains · High

The patent expiry of the diabetes/obesity drug semaglutide is set to flood India's market with over 40 generic versions, potentially expanding access but raising significant safety, regulatory, and quality control challenges. This case study highlights the critical balance between drug affordability and ensuring robust pharmacovigilance for complex biologic medicines.

Exam Lens

Quick Exam Facts From News

Drug in FocusSemaglutide
Expected Generic Brands40+
Previous Similar CaseDapagliflozin (100+ brands)
Drug TypeComplex Peptide (Injectable/Oral)

1-Minute Revision

  • ›Drug in Focus: Semaglutide
  • ›Expected Generic Brands: 40+
  • ›Target this Data: Over 40 generic brands expected post semaglutide patent expiry.
  • ›Target this Nodal Body: Central Drugs Standard Control Organization (CDSCO) for drug regulation.
  • ›Target this Concept: 'Complex peptide' vs. simple oral tablet for generic manufacturing challenges.

Mastered this topic? Test your knowledge with a full MCQ quiz.

Practice exam-style questions, track your score, and strengthen your recall.

Q1Static LinkageEasy

Which organization is primarily responsible for drug regulation and pharmacovigilance in India?

Q2Statement-basedHard

Consider the following statements regarding the news on semaglutide generics:

1. The patent expiry is expected to lead to the launch of over 40 generic brands in India.

2. Semaglutide is a simple oral tablet, making its generic manufacturing relatively straightforward.

3. A past example of similar generic market flooding in India is the drug Dapagliflozin.

Which of the statements given above is/are correct?

Q3Data-centricMedium

According to the article, what is the critical temperature range for the cold-chain storage of semaglutide during its primary supply chain to maintain shelf life?

Q4Application/ImpactMedium

What is cited in the article as a primary concern if educational guardrails do not keep pace with the availability of generic semaglutide?

All 15 MCQs ▸
You finished this topic
Explore Related Topics
Related Current Affairs
Polity Current Affairs

NTA Overhauls Translator Role: AI Handles Bulk Translation, Humans Review for Quality Assurance

The National Testing Agency (NTA) is restructuring its translation process for exam papers. Under the new system, AI will perform bulk translations, while human 'translation reviewers' will verify, certify, and quality-assure the AI output. This reform follows the NEET UG paper leak and aims to enhance security and accuracy in high-stakes exams.

Polity Current Affairs

FSSAI Initiates 3 Cases Against Nestlé India Over IMS Act, Biotin Levels

FSSAI has initiated three separate cases against Nestlé India for alleged violations of the IMS Act and food safety regulations related to infant formula promotional claims and biotin content. This action reinforces India's strict stance on protecting breastfeeding practices and regulating infant nutrition marketing. For exams, this links to the FSS Act, IMS Act, and regulatory enforcement mechanisms.

Polity Current Affairs

MeitY Summons Meta Global Team Over Algorithmic Bias; Parliamentary Panel to Question

Government summons Meta's global team to clarify algorithmic bias and role in public order after MeitY rejects technical glitch explanation. Parliamentary panel will also question the company. This highlights growing regulatory scrutiny on social media algorithms and their societal impact.

Social Issues Current Affairs

NOTTO Reports 20,000+ Transplants in 2025, Launches Portal and Swap Guidelines

NOTTO released 2025 data showing over 20,000 transplants, persistent gender disparity in organ donation (68% female donors vs 78% male recipients), and launched a new digital portal to enhance transparency. New swap transplantation guidelines aim to expand matching beyond single hospitals, but legal recognition under THOTA is still pending.

Polity Current Affairs

Health Ministry Amends Drugs Rules, 1945: New Debarment Power for Fake Data Cases

The Health Ministry has strengthened the Drugs Rules, 1945 to penalize applicants who submit fake data for drug approvals. Previously, only rejection/cancellation was possible; now licensing authorities can debar entities from filing new applications for a period, with show-cause notice and appeal provisions. This is crucial for exam questions on regulatory frameworks, pharmaceutical governance, and the Drugs & Cosmetics Act.

Social Issues Current Affairs

AI in Education: 11% of Papers Contain AI Text, Shift from Banning to Guided Use Needed

India's education system must move from fear-led restriction to structured enablement of AI. With 11% of student papers containing AI language, institutions need to define permitted use, require disclosure, and assess process over output. The article outlines two parallel strategies: using AI to teach better and teaching students to use AI better.

Social Issues Current Affairs

Meta Trial: $567 Mn Penalty for Child Addiction, 29-State Probe on Social Media Design

A US trial against Meta over addictive social media design for children could reshape Big Tech accountability. With penalties of $567 million and a $6 million jury verdict, this case highlights the growing scrutiny of platform design and its impact on youth mental health, a key issue for GS2 (Social Justice) and GS3 (Technology).

Social Issues Current Affairs

Karnataka Announces 7.5% Reservation for Rural Govt School Students in Medical, Engineering Seats

Karnataka CM Shivakumar announced a 7.5% reservation for rural government school students in medical and engineering courses to improve access to professional higher education. Additionally, AI education from Class 6, a government AI university in Bengaluru, and an exam reform committee were announced. This is significant for social justice and education policy in state exams.